prednisolone has been researched along with Migraine Disorders in 16 studies
Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.
Migraine Disorders: A class of disabling primary headache disorders, characterized by recurrent unilateral pulsatile headaches. The two major subtypes are common migraine (without aura) and classic migraine (with aura or neurological symptoms). (International Classification of Headache Disorders, 2nd ed. Cephalalgia 2004: suppl 1)
Excerpt | Relevance | Reference |
---|---|---|
" After percutaneous closure with the nickel-containing Amplatzer PFO occluder, the patient developed pericarditis, atrial fibrillation, and increased migraine headaches with aura that abated with oral prednisone." | 7.73 | Pericarditis associated with nickel hypersensitivity to the Amplatzer occluder device: a case report. ( Araujo, JA; Lai, DW; Reidl, M; Saver, JL; Tobis, J, 2005) |
" The administration of prednisolone led to the immediate improvement of her oculomotor palsy, but residual mydriasis remained." | 3.85 | Recurrent Painful Ophthalmoplegic Neuropathy with Residual Mydriasis in an Adult: Should it Be Classified as Ophthalmoplegic Migraine? ( Kobayashi, Y; Kondo, Y; Tsuyuzaki, J; Uchibori, K, 2017) |
" After percutaneous closure with the nickel-containing Amplatzer PFO occluder, the patient developed pericarditis, atrial fibrillation, and increased migraine headaches with aura that abated with oral prednisone." | 3.73 | Pericarditis associated with nickel hypersensitivity to the Amplatzer occluder device: a case report. ( Araujo, JA; Lai, DW; Reidl, M; Saver, JL; Tobis, J, 2005) |
"Prednisolone has no effect on withdrawal headache in unselected patients with chronic daily headache and medication overuse." | 2.73 | Prednisolone does not reduce withdrawal headache: a randomized, double-blind study. ( Bøe, MG; Mygland, A; Salvesen, R, 2007) |
"Cephalalgias are divided into four syndromes and the most severe of these, migraine, presents several therapeutic applications." | 2.38 | [Therapy of headache]. ( Cavanna, M, 1989) |
"After these treatment, his migraine attack disappeared." | 1.31 | [A case of migrainous infarction accompanying idiopathic thrombocytopenic purpura]. ( Hayashi, T; Katou, H; Kougo, K; Morihara, Y; Nanri, K; Niiyama, K; Sekine, S; Utsumi, H, 2002) |
"Data concerning status migrainosus in children and adolescents is sparse." | 1.31 | Status migrainosus in children and adolescents. ( Akhtar, ND; Murray, MA; Rothner, AD, 2001) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (31.25) | 18.7374 |
1990's | 1 (6.25) | 18.2507 |
2000's | 6 (37.50) | 29.6817 |
2010's | 3 (18.75) | 24.3611 |
2020's | 1 (6.25) | 2.80 |
Authors | Studies |
---|---|
Hoshina, Y | 1 |
Fallah, S | 1 |
Baker, V | 1 |
Kobayashi, Y | 1 |
Kondo, Y | 1 |
Uchibori, K | 1 |
Tsuyuzaki, J | 1 |
Llovet-Rausell, A | 1 |
Ruiz Tolosa, F | 1 |
Kudsieh, B | 1 |
Prakash, S | 1 |
Brahmbhatt, KJ | 1 |
Chawda, NT | 1 |
Tandon, N | 1 |
Saffra, N | 1 |
Smith, SN | 1 |
Seidman, CJ | 1 |
Sharma, K | 1 |
Wahi, J | 1 |
Phadke, RV | 1 |
Varma, A | 1 |
Jain, VK | 1 |
Nanri, K | 1 |
Niiyama, K | 1 |
Utsumi, H | 1 |
Sekine, S | 1 |
Katou, H | 1 |
Kougo, K | 1 |
Morihara, Y | 1 |
Hayashi, T | 1 |
Lai, DW | 1 |
Saver, JL | 1 |
Araujo, JA | 1 |
Reidl, M | 1 |
Tobis, J | 1 |
Bøe, MG | 1 |
Mygland, A | 1 |
Salvesen, R | 1 |
Peatfield, R | 1 |
Jacobi, G | 1 |
Ritz, A | 1 |
Berger, T | 1 |
Terashi, A | 1 |
Tezuka, H | 1 |
Akhtar, ND | 1 |
Murray, MA | 1 |
Rothner, AD | 1 |
Cavanna, M | 1 |
Groh, H | 1 |
Barolin, GS | 1 |
Chlud, K | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Medication Overuse Headache: A Randomised Double Blind Study of Prednisolone or Placebo in Withdrawal Therapy (Phase 3), and a Randomised 1 Year Follow up by Neurologist or General Physician After Successful Withdrawal Therapy[NCT00135122] | Phase 3 | 100 participants (Actual) | Interventional | 2003-09-30 | Completed | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
1 review available for prednisolone and Migraine Disorders
Article | Year |
---|---|
[Therapy of headache].
Topics: Cluster Headache; Dextropropoxyphene; Dihydroergotamine; Domperidone; Ergotamine; Headache; Humans; | 1989 |
1 trial available for prednisolone and Migraine Disorders
Article | Year |
---|---|
Prednisolone does not reduce withdrawal headache: a randomized, double-blind study.
Topics: Adolescent; Adult; Aged; Analgesics; Anxiety; Combined Modality Therapy; Depression; Double-Blind Me | 2007 |
14 other studies available for prednisolone and Migraine Disorders
Article | Year |
---|---|
Optic Neuritis Mimicking Migraine with Scintillating Scotoma.
Topics: Adult; Brain; Diagnosis, Differential; Glucocorticoids; Humans; Magnetic Resonance Imaging; Male; Mi | 2021 |
Recurrent Painful Ophthalmoplegic Neuropathy with Residual Mydriasis in an Adult: Should it Be Classified as Ophthalmoplegic Migraine?
Topics: Diplopia; Female; Humans; Magnetic Resonance Imaging; Middle Aged; Migraine Disorders; Mydriasis; Op | 2017 |
Severe ocular side effects with acetazolamide: case report.
Topics: Acetazolamide; Acute Disease; Adult; Brimonidine Tartrate; Cyclopentolate; Drug Therapy, Combination | 2016 |
Hemicrania continua responsive to intravenous methyl prednisolone.
Topics: Adult; Anti-Inflammatory Agents; Female; Humans; Injections, Intravenous; Migraine Disorders; Predni | 2009 |
Topiramate-induced refractive change and angle closure glaucoma and its ultrasound bimicroscopy findings.
Topics: Administration, Oral; Administration, Topical; Adult; Anticonvulsants; Female; Fructose; Glaucoma, A | 2012 |
Migraine-like visual hallucinations in occipital lesions of cysticercosis.
Topics: Adolescent; Adult; Albendazole; Anticonvulsants; Antiprotozoal Agents; Carbamazepine; Drug Therapy, | 2002 |
[A case of migrainous infarction accompanying idiopathic thrombocytopenic purpura].
Topics: 1-Naphthylamine; Adult; Blood Platelets; Cerebral Infarction; Humans; Male; Methacrylates; Migraine | 2002 |
Pericarditis associated with nickel hypersensitivity to the Amplatzer occluder device: a case report.
Topics: Adult; Cardiac Surgical Procedures; Echocardiography, Transesophageal; Glucocorticoids; Heart Septal | 2005 |
How to treat migraine.
Topics: Analgesics; Cluster Headache; Diagnosis, Differential; Ergotamine; Humans; Lithium; Migraine Disorde | 1984 |
[Migraine in children. Clinics, differential diagnosis, and therapy (author's transl)].
Topics: Adolescent; Analgesics; Brain Neoplasms; Caffeine; Cerebral Angiography; Cerebrovascular Disorders; | 1981 |
[Diagnosis and therapy of migraine and cluster headache].
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Analgesics; Calcium Channel Blockers; Child; Ergotam | 1993 |
Status migrainosus in children and adolescents.
Topics: Adolescent; Child; Diagnosis, Differential; Dihydroergotamine; Drug Therapy, Combination; Female; Fo | 2001 |
[Non-specific and specific therapy of syndromes of the cervical vertebrae].
Topics: Aminopyrine; Brachial Plexus Neuritis; Cortisone; Ergoloid Mesylates; Humans; Injections, Intra-Arti | 1966 |
[Headache in the temporal region].
Topics: Aged; Female; Giant Cell Arteritis; Headache; Humans; Male; Migraine Disorders; Polymyalgia Rheumati | 1968 |